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hands of an experienced bronchoscopist is probably needed to be able 
to perform EBUS-TBNA smoothly. 
EBUS-TBNA is a novel approach for the evaluation of the medias-
tinum. It is safe and has a good diagnostic yield. Further prospective 
studies describing the diagnostic yield of EBUS-TBNA compared to 
other conventional tools will be needed to support the value of this new 
modality. However EBUS-TBNA will possibly become a routine stag-
ing modality for lung cancer patients in the near future. 
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Owing to its aggressiveness, lung cancer is the main cause of all 
cancer-related deaths, with more than 150 000 deaths in the USA each 
year. Early detection of lung nodules is crucial for timely therapy. It 
is hoped that lung cancer screening of high-risk patient subjects may 
signiﬁcantly increase the rate of lung cancer cases that are diagnosed 
before the cancer has metastasised.
As recently as 1998, the most advanced CT scanners were single-detec-
tor CT scanners that required 30 seconds to image the entirety of the 
lungs with 10-mm sections. Today, multi-detector CT with 16 detector 
rows allows the entire lung to be scanned with 1-mm-thick sections in 
as little as 5 seconds. This improvement has the potential to increase 
diagnostic accuracy in pulmonary nodule detection compared with that 
at single-detector helical CT. However one drawback of high-resolu-
tion acquisitions is that the radiologists must examine up to 10 times 
the number of images that previously had to be examined. As a result, 
the efﬁciency of the interpreter is adversely affected. Furthermore, the 
increased likelihood of tedium-induced fatigue may adversely affect 
diagnostic accuracy, particularly because pulmonary lesions are more 
difﬁcult to discriminate from adjacent normal vascular structures as 
section thickness diminishes. In addition it has been shown that low 
dose technique used in screening programs, may be more difﬁcult for 
the radiologists to interpret images with increased image noise.
To reduce the number of false negative diagnosis, double reading has 
been proposed with signiﬁcant improvement in detection rate. However 
double reading is not always possible in routine clinical settings, espe-
cially because of limited human resources and cost effectiveness. Thus 
the use of a CAD scheme would be useful for assisting radiologists in 
cancer screening using CT and provide a solution to this problem.
CAD has generally been deﬁned by detection and diagnosis made by a 
physician who takes into account the computer output based on quan-
titative analysis of radiological images. The goal of CAD is to improve 
the quality and productivity of radiologists tasks by improving the ac-
curacy and consistency of radiological diagnoses and also by reducing 
the image reading time.
Two main approaches for CAD are: 1) to ﬁnd the location of a lesion, 
this corresponds to CAD for detection and 2) to determine an estimate 
of the probability of a disease, that corresponds to CAD for differential 
diagnosis. In the ﬁrst case the results of CAD are markers that draw the 
attention of the reader to locations of suspicious anomalies. A marker 
is considered as a true positive even if it points at a benign or calci-
ﬁed nodule; false positive markings are then those that do not point at 
nodules at all (but at scars, bronchial wall thickenings, motion artefacts, 
vessel bifurcations, etc.). The performance of CAD is usually given 
as a sensitivity (detection rate) and a false positive rate (false positive 
markings per CT study). In the second case automated computerised 
scheme have been developed for determination of the likelihood mea-
sure of malignancy by using various objective features. CAD software 
can compare the measured values in a multidimensional feature space 
to known benign and malignant example populations, retrieve similar 
cases with known diagnosis from a database or give a likelihood 
estimation for malignancy. In the context of CAD for diagnosis false 
positives are then nodules that are judged to be malignant while really 
being benign nodules. CAD faces a classical yes/no decision problem, 
or at least an outcome range that can be normalised to a 0 to 1 interval, 
so that its performance can be rated by normalised sensitivity and 
speciﬁcity. Among the various needs for quantiﬁcation of lung nodules, 
volume measurement (volumetry) of a detected nodule is the most 
immediate (for reporting) and the most basic (for detection of possible 
growth in a follow-up examination). 
CAD can be applied to all imaging modalities for all body parts. 
However the majority of CAD schemes developed in the past include 
the detection of breast lesions in mammograms, the detection of lung 
nodules in chest radiographs and thoracic CT and the detection of 
polyps in CT colonography. CAD system for detection of breast lesions 
was approved by US FDA in 1998. Subsequently clinical use of the 
mammographic CAD system has began in many screening sites with a 
gain in the early detection of breast cancer of 20% in mammograms.
In 2001, Deus technologies developed another CAD system for the 
detection of lung nodules on chest radiographs and received FAD ap-
proval for its clinical use. A number of prototype system for detection 
of pulmonary nodules in thoracic CT have been developed and are 
under evaluation around the world. 
The large majority of computer-aid lung nodule detection have been 
designed in the last decade for conventional 5-10 mm CT slice thick-
ness however the reported sensitivity and speciﬁcity rates were often 
too low and didn’t reach the level of clinical acceptance and usefulness. 
On one hand the detection rate was not sufﬁcient, while on the other 
hand the false positive rate was sometimes so high that it annoyed 
radiologists. A typical study on single slice CT data reports only 38% 
sensitivity with six false positives per patient. Another study reports 
72% sensitivity with 31 false positives per patient. 
The principal problem of computerised nodule detection in thick slices 
of 5-10 mm is that the opacity of nodules that are smaller than the 
slice thickness is reduced to subsolid appearance by the partial volume 
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effect. Therefore it is impossible to set a certain Hounsﬁeld value as a 
threshold for potential nodule.
With the advent of multi-slice CT the quality of image has been 
considerably improved over that of conventional CT with thick slices, 
thus the performance of CAD schemes in the detection of nodules on 
MDCT has generally been improved. At ﬁrst high resolution CT was 
used mainly for segmentation, characterisation and classiﬁcation of 
already identiﬁed nodules. More recently HRCT data have also been 
used for nodule detection. The sensitivity of CAD system alone has 
been assessed with reported sensitiveness up to 84%. One of the best 
performance of a lung nodule CAD system (Philips Research, Ham-
burg, Germany) has been recently reported by Wiemker et al. on a pilot 
study conducted in the years 2000-2001 by a 4-slice scanner over the 
entire thorax at 120 kV and 100 mAs with a slice thickness of 1 mm. In 
addition to the radiologist, the thoracic data sets were read by the CAD 
software (computation time was approximately 1 min for all 300-500 
slices per thorax). The automated detection showed a sensitivity of 
84% (detection rate including nodules of all sizes). If the minimum 
nodule size for detection was set to 2 mm, the sensitivity was 95% with 
4.4 false positives per patient. Although these are encouraging results, 
such a high detection rate at an equally low false positive rate can not 
be expected in all clinical settings. For example examinations may be 
taken with low dose imaging protocols. 
In our Institute we recently tested the performances of two different 
CADs for the detection of lung nodules (i.e. diameter > 6 mm) and 
early stage lung cancers using low-dose CT of the lung. All low-dose 
CT scans were obtained with a 8- or 16-section CT scanner (General 
Electric, Milwaukee, WI, USA) with the following parameters: 140 
kVp, 30 mA, 1.75:1 pitch ratio, and 2.5 mm slice thickness. Native 
DICOM images were sent and processed using two different CAD 
systems (LMS-Lung, MedianTechnologies and Lung VCARE, General 
Electric Medical System). Both CAD systems, applying multiple and 
different algorithms, automatically detect and segment potential regions 
of interest that are marked on CT scan. Each mark were subsequently 
accepted or refused by radiologists, mentioning results in a written 
report. Accepted nodules were automatically extracted using a 3D-
template method. Image data have been extracted from our data-base 
of 16.000 low-dose CT. The scan of a series of 90 patients with lung 
cancer and a series of 90 subjects with at least one benign lung nodule 
> 5 mm (conﬁrmed by at least 1-year follow-up) have been selected 
and the results of CAD analysis have been compared with the diagnosis 
made by the expert Radiologist before and after consideration of the 
CAD results to obtain true and false positive and negative results. The 
preliminary results of the study have demonstrated a relatively low sen-
sitivity for both CAD systems alone (less than 60%) but a signiﬁcant 
role of CAD as a second reader in increasing the detection rate of the 
radiologists with a limited rate of false positives per scan (0.7-1.5).
In conclusion, with the excellent spatial resolution of modern mul-
tislice CT scanners and their ability to acquire a thoracic scan within 
one breath-hold, software algorithms for computer-aided detection 
(CAD) of pulmonary nodules are now reaching high sensitivity levels 
at moderate false positive rates. A number of pilot studies have shown 
that CAD modules can successfully ﬁnd overlooked pulmonary nodules 
and serve as a powerful tool for diagnostic quality assurance. Equally 
important are tools for fast and accurate three-dimensional volume 
measurement of detected nodules. These allow monitoring of nodule 
growth between follow-up examinations for differential diagnosis and 
response to oncological therapy. Owing to decreasing partial volume 
effect, nodule volumetry is more accurate with high resolution CT data.
The current results obtained from research of CAD may be considered 
the tip of a iceberg and a major impact of CAD on medical imaging and 
diagnostic radiology maybe expected in the future.
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Solitary pulmonary opacities are common and the increasing use of CT 
together with improvements in CT image acquisition and quality has 
resulted in a high incidence of detection. Most incidentally discovered 
nodules are benign and despite an extensive differential diagnosis are 
usually the sequelae of pulmonary infection. Nevertheless, a signiﬁcant 
proportion of lung cancers manifest as solitary pulmonary opacities. 
Because the prognosis of lung cancer depends on a number of factors 
including stage at presentation, there is an emphasis on early diagnosis 
and consequently CT and positron emission tomography (PET) imag-
ing are often used to evaluate focal pulmonary opacities.
CT optimally evaluates the growth rate and morphological character-
istics (size, margins, contour, internal morphology) that can be useful 
in distinguishing benign from malignant nodules. CT is the modality 
of choice in the assessment of a nodules growth rate and it is generally 
accepted that the absence of visible growth over a 2-year period is reli-
able in determining benignity. However, in a screening study analyzing 
the growth rates of small lung cancers, it was found that approximately 
20% of these opacities had a volumetric doubling time greater than 
2 years. The concern raised about conferring benignity to a lesion 
based on the absence of growth over 2 years is particularly important 
when the accuracy of growth assessment in small nodules is consid-
ered. However, the use of CT does in most cases allows an accurate 
assessment of growth and it has been recently reported that growth 
can be detected in lung cancers as small as 5 mm when CT imaging is 
repeated within a 30 day interval. Furthermore, the measurement of se-
rial volumes, rather than diameters, and computer calculated doubling 
of volume of small nodules has been suggested to be an accurate and 
potentially useful method to assess growth. 
In terms of morphology, the likelihood of malignancy increases the 
larger the opacity is. However, the widespread use and improvements 
in CT, coupled with CT screening for lung cancer, has resulted in the 
frequent detection small nodules. While the majority of these nodules 
are benign, small size does not exclude malignancy. The margin and 
contour of a solitary pulmonary opacity can also be used to distinguish-
ing benign from malignant nodules: benign nodules typically have 
well-deﬁned margins and a smooth contour while malignant nodules 
have poorly deﬁned or spiculated margins and a lobular or irregular 
contour. However, there is considerable overlap between benign and 
malignant nodules regarding margins and contour and up to 20% of pri-
